An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer’s Disease

@article{Busschbach1998AnOF,
  title={An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer’s Disease},
  author={Dr Jan J.V. Busschbach and Werner B. F. Brouwer and Adrianus van der Donk and Jan Passchier and Frans F. H. Rutten},
  journal={PharmacoEconomics},
  year={1998},
  volume={13},
  pages={21-34}
}
This article provides an outline for a cost-effectiveness analysis of a drug that slows the consequences of Alzheimer’s disease. Such an analysis cannot easily be performed for 2 main reasons. The first is that often relatives and friends, rather than professionals, take care of the patient. This means that informal care plays an important role in the… CONTINUE READING